Shuo Lin

645 total citations
38 papers, 435 citations indexed

About

Shuo Lin is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Shuo Lin has authored 38 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Endocrinology, Diabetes and Metabolism, 11 papers in Molecular Biology and 9 papers in Surgery. Recurrent topics in Shuo Lin's work include Diabetes Management and Research (10 papers), Diabetes Treatment and Management (9 papers) and Metabolism, Diabetes, and Cancer (8 papers). Shuo Lin is often cited by papers focused on Diabetes Management and Research (10 papers), Diabetes Treatment and Management (9 papers) and Metabolism, Diabetes, and Cancer (8 papers). Shuo Lin collaborates with scholars based in China and Australia. Shuo Lin's co-authors include Jianhui Fan, Jinhui Cui, Liyuan Zou, Ling Li, Bingyuan Wu, Xiaokun Ma, Shuisheng Zhou, Panwei Mu, Ping Li and Yanming Chen and has published in prestigious journals such as Diabetes, Clinica Chimica Acta and Clinical Endocrinology.

In The Last Decade

Shuo Lin

35 papers receiving 430 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shuo Lin China 12 181 139 115 111 79 38 435
Cynthia R. Hill United States 8 51 0.3× 185 1.3× 40 0.3× 104 0.9× 31 0.4× 8 395
Spyridon Gerou Greece 10 57 0.3× 147 1.1× 50 0.4× 68 0.6× 14 0.2× 31 393
Jana Kloučková Czechia 13 93 0.5× 101 0.7× 44 0.4× 82 0.7× 25 0.3× 23 454
Yuichi Fujinaka Japan 11 135 0.7× 201 1.4× 32 0.3× 235 2.1× 17 0.2× 17 463
Susana Belli Argentina 11 164 0.9× 150 1.1× 20 0.2× 42 0.4× 28 0.4× 28 515
Katsuya Matsuda Japan 12 90 0.5× 105 0.8× 39 0.3× 57 0.5× 24 0.3× 45 406
Hitoo Nakano Japan 12 33 0.2× 202 1.5× 467 4.1× 79 0.7× 48 0.6× 15 835
Akashi Taguchi Japan 7 44 0.2× 254 1.8× 15 0.1× 40 0.4× 126 1.6× 11 406
Andrzej Witek Poland 10 24 0.1× 102 0.7× 63 0.5× 25 0.2× 63 0.8× 57 292
Haluk Alagöl Türkiye 14 129 0.7× 51 0.4× 17 0.1× 256 2.3× 102 1.3× 37 508

Countries citing papers authored by Shuo Lin

Since Specialization
Citations

This map shows the geographic impact of Shuo Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuo Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuo Lin more than expected).

Fields of papers citing papers by Shuo Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuo Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuo Lin. The network helps show where Shuo Lin may publish in the future.

Co-authorship network of co-authors of Shuo Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Shuo Lin. A scholar is included among the top collaborators of Shuo Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuo Lin. Shuo Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Wen, et al.. (2025). Insulin Requirement Profiles of Short‐Term Continuous Subcutaneous Insulin Infusion Therapy in Patients With Type 2 Diabetic Nephropathy. International Journal of Endocrinology. 2025(1). 8403917–8403917. 1 indexed citations
2.
Chen, Yuqing, Shuo Lin, Xiaojing Huang, & Wen Zhou. (2025). From biofilm control to biomimetic remineralization: Hydrogels in prevention and treatment of dental caries. Frontiers in Cellular and Infection Microbiology. 15. 1663563–1663563.
3.
Zeng, Wen, et al.. (2023). Caveolin-1 deficiency alleviates palmitate-induced intracellular lipid accumulation and inflammation in pancreatic β cells. Journal of Physiology and Biochemistry. 80(1). 175–188.
4.
Cai, Nan, Xuanrong Chen, Jia Liu, et al.. (2023). Glucokinase activator improves glucose tolerance and induces hepatic lipid accumulation in mice with diet-induced obesity. Liver Research. 7(2). 124–135. 2 indexed citations
5.
Li, Ping, Jinhui Cui, Ling Li, et al.. (2022). Association between isolated maternal hypothyroxinemia during the first trimester and adverse pregnancy outcomes in Southern Chinese women: a retrospective study of 7051 cases. BMC Pregnancy and Childbirth. 22(1). 866–866. 10 indexed citations
6.
Li, Ping, et al.. (2021). Impact of Early Pregnancy Subclinical Hypothyroidism on Gestational Diabetes Mellitus: A Retrospective Study of 7,536 Cases. Journal of Women s Health. 31(2). 293–298. 8 indexed citations
7.
Zhang, Yao, et al.. (2021). Dietary Knowledge, Attitude and Practice (KAP) Among the Family Members of Patients with Type 2 Diabetes Mellitus (T2DM) and Its Influence on the KAP of T2DM Patients. Diabetes Metabolic Syndrome and Obesity. Volume 14. 205–213. 10 indexed citations
8.
Xu, Weiran, et al.. (2020). Development and Validation of a Hypoglycemia Risk Model for Intensive Insulin Therapy in Patients with Type 2 Diabetes. Journal of Diabetes Research. 2020. 1–7. 10 indexed citations
9.
Chen, Xinjuan, et al.. (2020). MiR-101-containing extracellular vesicles bind to BRD4 and enhance proliferation and migration of trophoblasts in preeclampsia. Stem Cell Research & Therapy. 11(1). 231–231. 41 indexed citations
10.
Li, Ping, Shuo Lin, Ling Li, et al.. (2019). First-trimester fasting plasma glucose as a predictor of gestational diabetes mellitus and the association with adverse pregnancy outcomes. Pakistan Journal of Medical Sciences. 35(1). 95–100. 33 indexed citations
11.
Li, Ping, Shuo Lin, Ling Li, et al.. (2019). Utility of MELD scoring system for assessing the prognosis of acute fatty liver of pregnancy. European Journal of Obstetrics & Gynecology and Reproductive Biology. 240. 161–166. 8 indexed citations
12.
13.
Li, Haicheng, Haixia Xu, Fen Xu, et al.. (2018). The effects of caveolin1 on β cell proliferation. Cellular and Molecular Biology. 64(1). 40–46. 3 indexed citations
14.
Lin, Shuo, Mu Chen, Wanling Chen, et al.. (2018). A Randomized Trial of Insulin Glargine plus Oral Hypoglycemic Agents versus Continuous Subcutaneous Insulin Infusion to Treat Newly Diagnosed Type 2 Diabetes. Journal of Diabetes Research. 2018. 1–9. 1 indexed citations
15.
Zeng, Wen, Haicheng Li, Haixia Xu, et al.. (2018). Caveolin-1 deficiency protects pancreatic β cells against palmitate-induced dysfunction and apoptosis. Cellular Signalling. 47. 65–78. 24 indexed citations
16.
Li, Ping, Shuo Lin, Jinhui Cui, et al.. (2017). First Trimester Neck Circumference as a Predictor for the Development of Gestational Diabetes Mellitus. The American Journal of the Medical Sciences. 355(2). 149–152. 14 indexed citations
17.
Li, Ping, Yuzhu Yin, Shuo Lin, et al.. (2016). Utility of Pregestational Body Mass Index and Initial Fasting Plasma Glucose in Predicting Gestational Diabetes Mellitus. The American Journal of the Medical Sciences. 351(4). 420–425. 10 indexed citations
18.
Tang, Xixiang, Suhua Li, Yina Wang, et al.. (2016). Glycemic variability evaluated by continuous glucose monitoring system is associated with the 10-y cardiovascular risk of diabetic patients with well-controlled HbA1c. Clinica Chimica Acta. 461. 146–150. 65 indexed citations
19.
Wang, Manman, Shuo Lin, Yanming Chen, et al.. (2015). Saxagliptin is similar in glycaemic variability more effective in metabolic control than acarbose in aged type 2 diabetes inadequately controlled with metformin. Diabetes Research and Clinical Practice. 108(3). e67–e70. 11 indexed citations
20.
Li, Xu, et al.. (2000). [Bone mineral density and exercises: a cross-sectional study on Chinese athletes].. PubMed. 22(1). 61–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cynthia R. Hill Breakdown of academic impact, for papers by Spyridon Gerou Breakdown of academic impact, for papers by Jana Kloučková Breakdown of academic impact, for papers by Yuichi Fujinaka Breakdown of academic impact, for papers by Susana Belli Breakdown of academic impact, for papers by Katsuya Matsuda Breakdown of academic impact, for papers by Hitoo Nakano Breakdown of academic impact, for papers by Akashi Taguchi Breakdown of academic impact, for papers by Andrzej Witek Breakdown of academic impact, for papers by Haluk Alagöl
Rankless by CCL
2026